Company Filing History:
Years Active: 2015-2020
Title: Joël Richard: Innovator in Pharmaceutical Compositions
Introduction
Joël Richard is a notable inventor based in Méré, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release drug compositions. With a total of 3 patents to his name, Richard's work focuses on enhancing the efficacy of peptide therapeutics.
Latest Patents
Richard's latest patents include a pharmaceutical composition for a sustained release of lanreotide. This innovative composition is designed for a sustained release compatible with therapeutic treatments lasting at least two months. It comprises lanreotide as the active agent, a hydrosoluble co-solvent, and water, with a pH ranging from 4.0 to 7.5. Another significant patent is a sustained-release composition containing peptides as the active ingredient. This invention consists of microparticles of a peptide and a biocompatible water-soluble polymer, specifically targeting melanocortin receptor ligands. Additionally, it includes an injection formulation that suspends the sustained-release drug composition in an injection medium.
Career Highlights
Joël Richard is associated with Ipsen Pharma S.a.s., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug delivery systems, particularly for peptide-based therapies.
Collaborations
Richard collaborates with esteemed colleagues such as Roland Cherif-Cheikh and Faïza Laredj, contributing to a dynamic research environment that fosters innovation.
Conclusion
Joël Richard's contributions to pharmaceutical compositions exemplify the importance of innovation in drug delivery systems. His patents reflect a commitment to improving therapeutic outcomes for patients.